Ledger.Open graph →
SEC Form D · filed April 17, 2019

Cyclerion Therapeutics, Inc

Offering
$175.0M
Sold
$175.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Cambridge, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Stephanie E. Lovell · Cambridge, MADirectorMark G. Currie · Cambridge, MAExecTerrance E. Mcguire · Cambridge, MADirectorMichael E. Mendelsohn · Cambridge, MADirectorMarsha E. Fanucci · Cambridge, MADirectorKevin E. Churchwell · Cambridge, MADirectorOle E. Isacson · Cambridge, MADirectorWilliam G. Huyett · Cambridge, MAExecAmy E. Schulman · Cambridge, MADirectorGeorge E. Conrades · Cambridge, MADirectorPeter M. Hecht · Cambridge, MAExec · DirectorAriel E. Berkman · Herzliya, L3DirectorRobert C. Pew · Portland, ORDirectorBrianna C. Griffith · Portland, ORExecKalen B. Caughey · Portland, ORDirectorRyan P. Rosenbaum · Kansas City, MODirectorStacey M. Berger · Portland, ORDirectorScott C. Bedford · Portland, ORExecByron C. Caughey · Portland, ORExec · DirectorHarpinder S. Madan · Palo Alto, CADirectorJohn P. Bertrand · Kansas City, MODirectorEvan B. Caughey · Portland, ORDirectorCameron Chell · CALGARY, Alberta, CanadaDirectorR. G. Whaling · Houston, TXDirectorDon P. Ronchi · Miami, FLDirectorSteven E. Oh · New York, NYDirectorWilliam H. Parkerson · Overland Park, KSDirectorPeter F. Cortelyou · Leawood, KSDirectorSteven N. Palmer · Kansas City, MOExecThomas R. Willard · Kansas City, MOExecJeremy R. Mclendon · Virginia Beach, VAExec · DirectorCharles Mallory · Stamford, CTDirectorChris E. Celano · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗